A common variant of CDKN2A (p16) predisposes to breast cancer

被引:61
|
作者
Debniak, T
Górski, B
Huzarski, T
Byrski, T
Cybulski, C
Mackiewicz, A
Gozdecka-Grodecka, S
Gronwald, J
Kowalska, E
Haus, O
Grzybowska, E
Stawicka, M
Swiec, M
Urbanski, K
Niepsuj, S
Wasko, B
Gózdz, S
Wandzel, P
Szczylik, C
Surdyka, D
Rozmiarek, A
Zambrano, O
Posmyk, M
Narod, SA
Lubinski, J
机构
[1] Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada
[2] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland
[3] Dept Canc Immunol, Poznan, Poland
[4] Dept Clin Genet, Bydgoszcz, Poland
[5] Maria Sklodowska Curie Inst, Dept Tumour Biol, Gliwice, Poland
[6] Prophylact & Epidemiol Ctr, Poznan, Poland
[7] Reg Oncol Hosp, Opole, Poland
[8] Reg Oncol Ctr, Krakow, Poland
[9] Reg Oncol Hosp, Olsztyn, Poland
[10] Reg Hosp, Rzeszow, Poland
[11] Holycross Oncol Ctr, Kielce, Poland
[12] Reg Hosp, Bielsko Biala, Poland
[13] Mil Hosp, Warsaw, Poland
[14] Reg Hosp, Lublin, Poland
[15] Reg Oncol Hosp, Zielona Gora, Poland
[16] Reg Hosp, Lodz, Poland
[17] Reg Oncol Hosp, Bialystok, Poland
关键词
D O I
10.1136/jmg.2005.031476
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: A common missense variant of the CDKN2A gene (A148T) predisposes to malignant melanoma in Poland. An association between malignant melanoma and breast cancer has been reported in several families with CDKN2A mutations, Objective: To determine whether this variant also predisposes to breast cancer. Methods: Genotyping was undertaken in 4209 cases of breast cancer, unselected for family history, from 18 hospitals throughout Poland and in 3000 controls. Results: The odds ratio ( OR) associated with the CDKN2A allele for women diagnosed with breast cancer before the age of 50 was 1.5 ( p = 0.002) and after age 50 it was 1.3 ( p = 0.2). The effect was particularly strong for patients diagnosed at or before the age of 30 ( OR = 3.8; p = 0.0002). Conclusions: CDKN2A appears to be a low penetrance breast cancer susceptibility gene in Poland. The association should be confirmed in other populations.
引用
收藏
页码:763 / 765
页数:3
相关论文
共 50 条
  • [31] Telomerase activity and inactivation of the tumor suppressor gene p16 (CDKN2A) in head and neck cancer
    Koscielny, S
    Dahse, R
    Beleites, E
    Fiedler, W
    4TH EUROPEAN CONGRESS OF OTO-RHINO-LARYNGOLOGY HEAD AND NECK SURGERY, VOLS 1 AND 2, 2000, : 699 - 706
  • [32] Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing
    Bihl, Michel P.
    Foerster, Anja
    Lugli, Alessandro
    Zlobec, Inti
    JOURNAL OF TRANSLATIONAL MEDICINE, 2012, 10
  • [33] Characterization of CDKN2A(p16) methylation and impact in colorectal cancer: systematic analysis using pyrosequencing
    Michel P Bihl
    Anja Foerster
    Alessandro Lugli
    Inti Zlobec
    Journal of Translational Medicine, 10
  • [34] Surgical outcomes after pancreatic surgery in patients with a germline CDKN2A/p16 pathogenic variant under surveillance
    Onnekink, Anke M.
    Michiels, Nynke
    Klatte, Derk C. F.
    Oldenburg, Lotte
    Mieog, J. Sven D.
    Vahrmeijer, Alexander L.
    van Hooft, Jeanin E.
    van Leerdam, Monique E.
    Bonsing, Bert A.
    BRITISH JOURNAL OF SURGERY, 2024, 111 (01)
  • [35] Malignant transformation of neurofibromas in neurofibromatosis 1 is associated with CDKN2A/p16 inactivation
    Nielsen, GP
    Stemmer-Rachamimov, AO
    Ino, Y
    Moller, MB
    Rosenberg, AE
    Louis, DN
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06): : 1879 - 1884
  • [36] Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial Carcinoma
    Li Su
    Hanwei Wang
    Jingwei Miao
    Ying Liang
    Scientific Reports, 5
  • [37] Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families
    Emanuel Yakobson
    Pnina Shemesh
    Esther Azizi
    Eyal Winkler
    Norman Lassam
    David Hogg
    Sharon Brookes
    Gordon Peters
    Michal Lotem
    Abraham Zlotogorski
    Marina Landau
    Mark Safro
    Raphael Shafir
    Eitan Friedman
    Hava Peretz
    European Journal of Human Genetics, 2000, 8 : 590 - 596
  • [38] Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial Carcinoma
    Su, Li
    Wang, Hanwei
    Miao, Jingwei
    Liang, Ying
    SCIENTIFIC REPORTS, 2015, 5
  • [39] Absence of p16 gene (CDKN2A) deletions in HNSCC occurring in young adults
    O'Regan, EM
    Sheils, OM
    Murphy, NC
    Ring, M
    Toner, ME
    Finn, SP
    Smyth, PC
    Cahill, S
    O'Leary, JJ
    LABORATORY INVESTIGATION, 2005, 85 : 216A - 216A
  • [40] Role of CDKN2A/p16 expression in the prognostication of oral squamous cell carcinoma
    Padhi, Swati Shree
    Roy, Souvick
    Kar, Madhabananda
    Saha, Arka
    Roy, Shomereeta
    Adhya, Amit
    Baisakh, Manas
    Banerjee, Birendranath
    ORAL ONCOLOGY, 2017, 73 : 27 - 35